missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ IMP3 Polyclonal Antibody

Goat Polyclonal Antibody
Brand: Invitrogen™ PA519335
This item is not returnable.
View return policy
Description
This antibody is predicted to react with bovine, canine, mouse, porcine and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 4,000.
This gene encodes the human homolog of the yeast Imp3 protein. The protein localizes to the nucleoli and interacts with the U3 snoRNP complex. The protein contains an S4 domain.
Specifications
| IMP3 | |
| Polyclonal | |
| Unconjugated | |
| Imp3 | |
| 1190002L16Rik; AI256594; BRMS2; C15orf12; cancer/testis antigen 98; CT98; DKFZp586L0118; FLJ10968; hKOC; IGF2 mRNA-binding protein 3; IGF2BP3; IGF-II mRNA-binding protein 3; IMP3; IMP-3; IMP3, U3 small nucleolar ribonucleoprotein; IMP3, U3 small nucleolar ribonucleoprotein, homolog; IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast); insulin like growth factor 2 mRNA binding protein 3; insulin-l; insulin-like growth factor 2 mRNA binding protein 3; insulin-like growth factor 2 mRNA-binding protein 3; KH domain containing protein overexpressed in cancer; KH domain-containing protein overexpressed in cancer; KOC; KOC1; MRPS4; OTTHUMP00000183524; RGD1306825; U3 small nucleolar ribonucleoprotein protein IMP3; U3 snoRNP protein 3 homolog; U3 snoRNP protein IMP3; VICKZ family member 3; VICKZ3 | |
| Goat | |
| Ammonium sulfate precipitation | |
| RUO | |
| 55272 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| Q9NV31 | |
| Imp3 | |
| Synthetic peptide sequence (QRREDYTRYNQLSR) corresponding to the internal amino acids of IMP3 (aa 40-54). | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction